Treatment Archives | Page 25 of 38

People who were directly affected by the Sept. 11 terrorist attacks can receive screenings and care for medical conditions, including certain cancers, through the World Trade Center Health Program.

by Brad Jones

What Is ‘Chemo Brain’?

The National Cancer Institute's Todd Horowitz discusses cancer-related cognitive impairment.

by Anna Azvolinsky

From the Editor-in-Chief

Synthetic Lethality and Cancer: Aiming an Arrow at Achilles’ Heel

Insights about synthetic lethality have been used to develop cancer treatments.

by William G. Nelson, MD, PhD

Recognizing AI’s Potential

Pathologists and radiologists are leading the way in the use of artificial intelligence (AI) to find and track cancer. Machine learning could lay the foundation for using AI more broadly to advance cancer diagnosis and choice of treatment.

by Stephen Ornes

Forward Look

From Cold Virus to Cancer Fighter

Neurosurgeon Frederick F. Lang discusses virus-powered cancer treatments.

by Sue Rochman

Forward Look

Opening Clinical Trials to HIV-Positive Cancer Patients

Including patients with HIV is part of a larger effort to broaden cancer clinical trial eligibility.

by Andy Kopsa

Pushing the Immune System to Its Limits

Immunotherapy drugs have led to long-lasting remissions for some cancer patients with advanced disease. They also come with a new and diverse array of side effects.

by Kate Yandell

What Older Patients Value

Many older adults with cancer place more importance on maintaining their independence and cognitive abilities than on living as long as possible.

by Cheryl Platzman Weinstock

Omitting Obesity

Many cancer clinical trials do not track what proportion of enrolled patients are obese, a study finds. These patients may be underrepresented in research.

by Cici Zhang

Measuring Your Movement

Researchers are exploring whether wearable personal activity monitors could provide doctors with a more complete picture of cancer patients' well-being.

by Brad Jones